Abstract
It is commonly accepted that melatonin (N-acetyl-5-methoxytryptamine), the most relevant pineal secretory product, has oncostatic properties in a wide variety of tumors and, especially, in those identified as being hormone-dependent. The objective of the present article is to offer a global and integrative view of the mechanisms involved in the oncostatic actions of this indoleamine. Due to the wide spectrum of melatonins actions, the mechanisms that may be involved in its ability to counteract tumor growth are varied. These include: a) antioxidant effects; b) regulation of the estrogen receptor expression and transactivation; c) modulation of the enzymes involved in the local synthesis of estrogens; d) modulation of cell cycle and induction of apoptosis; e) inhibition of telomerase activity; f) inhibition of metastasis; g) prevention of circadian disruption; h) antiangiogenesis; i) epigenetic effects; j) stimulation of cell differentiation; and k) activation of the immune system. The data supporting each of these oncostatic actions of melatonin are summarized in this review. Moreover, the list of actions described may not be exhaustive in terms of how melatonin modulates tumor growth.
Keywords: Melatonin, cancer, antioxidant, immunoenhancing, estrogen signalling pathway, angiogenesis, telomerase, metastasis, epigenetic effects, indoleamine, malignant tumors, Neuroendocrin, neoplastic diseases, malignant neoplasias, sarcomas, colorectal cancer, hepatocarcinomas, melanoma, neural tumors, larynx carcinomas, cervical cancer, estrogenic receptor, mitogenic proteins, calmodulin (CaM), osteoblasts, aortic smooth muscle, antiaromatases, anastroxole, exemestrane, letrozole, estrogen sulfotransferases, mesenchymal stem cells, cytodifferentiating effects, cytosolic proteases, apoptotic induced factor, vincristine, ifosfamide, telomerase activity, xenoestrogens, reactive oxygen species, carbonic anhydrase IX, suprachiasmatic nuclei, E-cadherin, 1-integrin, lymphoid organs, lymphocytes, pinealectomy, epidermal growth factor receptor (EGFR), mitogenactivated protein kinase (MAPK), 13-hydroxyoctadecadienoic acid, neuroendocrine-reproductive, neoplasias
Current Medicinal Chemistry
Title: Basic Mechanisms Involved in the Anti-Cancer Effects of Melatonin
Volume: 17 Issue: 36
Author(s): M. D. Mediavilla, E. J. Sanchez-Barcelo, D. X. Tan, L. Manchester and R. J. Reiter
Affiliation:
Keywords: Melatonin, cancer, antioxidant, immunoenhancing, estrogen signalling pathway, angiogenesis, telomerase, metastasis, epigenetic effects, indoleamine, malignant tumors, Neuroendocrin, neoplastic diseases, malignant neoplasias, sarcomas, colorectal cancer, hepatocarcinomas, melanoma, neural tumors, larynx carcinomas, cervical cancer, estrogenic receptor, mitogenic proteins, calmodulin (CaM), osteoblasts, aortic smooth muscle, antiaromatases, anastroxole, exemestrane, letrozole, estrogen sulfotransferases, mesenchymal stem cells, cytodifferentiating effects, cytosolic proteases, apoptotic induced factor, vincristine, ifosfamide, telomerase activity, xenoestrogens, reactive oxygen species, carbonic anhydrase IX, suprachiasmatic nuclei, E-cadherin, 1-integrin, lymphoid organs, lymphocytes, pinealectomy, epidermal growth factor receptor (EGFR), mitogenactivated protein kinase (MAPK), 13-hydroxyoctadecadienoic acid, neuroendocrine-reproductive, neoplasias
Abstract: It is commonly accepted that melatonin (N-acetyl-5-methoxytryptamine), the most relevant pineal secretory product, has oncostatic properties in a wide variety of tumors and, especially, in those identified as being hormone-dependent. The objective of the present article is to offer a global and integrative view of the mechanisms involved in the oncostatic actions of this indoleamine. Due to the wide spectrum of melatonins actions, the mechanisms that may be involved in its ability to counteract tumor growth are varied. These include: a) antioxidant effects; b) regulation of the estrogen receptor expression and transactivation; c) modulation of the enzymes involved in the local synthesis of estrogens; d) modulation of cell cycle and induction of apoptosis; e) inhibition of telomerase activity; f) inhibition of metastasis; g) prevention of circadian disruption; h) antiangiogenesis; i) epigenetic effects; j) stimulation of cell differentiation; and k) activation of the immune system. The data supporting each of these oncostatic actions of melatonin are summarized in this review. Moreover, the list of actions described may not be exhaustive in terms of how melatonin modulates tumor growth.
Export Options
About this article
Cite this article as:
D. Mediavilla M., J. Sanchez-Barcelo E., X. Tan D., Manchester L. and J. Reiter R., Basic Mechanisms Involved in the Anti-Cancer Effects of Melatonin, Current Medicinal Chemistry 2010; 17 (36) . https://dx.doi.org/10.2174/092986710794183015
DOI https://dx.doi.org/10.2174/092986710794183015 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Secretory Leukocyte Protease Inhibitor: More than Just A Protease Inhibitor
Current Immunology Reviews (Discontinued) Non-Genotoxic p53-Activators and their Significance as Antitumor Therapy of Future
Current Medicinal Chemistry Nano-Chitosan Particles in Anticancer Drug Delivery: An Up-to-Date Review
Mini-Reviews in Medicinal Chemistry Cervical Cancer Diagnosis: Insights into Biochemical Biomarkers and Imaging Techniques
Combinatorial Chemistry & High Throughput Screening Development of New Therapeutic Agents for Fibrodysplasia Ossificans Progressiva.
Current Molecular Medicine Editorial [Hot Topic: Tumor Immunology (Guest Editors: Bharat H. Joshi and Raj K. Puri)]
Current Molecular Medicine Anticancer Activity and Anti-inflammatory Studies of 5-Aryl-1,4-benzodiazepine Derivatives
Anti-Cancer Agents in Medicinal Chemistry Natural Products as Anticancer Agents
Current Drug Targets Interrelated Roles for the Aryl Hydrocarbon Receptor and Hypoxia Inducible Factor-1α in the Immune Response to Infection
Current Immunology Reviews (Discontinued) Synthesis and Antitumor Activity Evaluation of New Phenanthrene-Based Tylophorine Derivatives
Letters in Organic Chemistry A Comprehensive Review on the Genetic Regulation of Cisplatin-induced Nephrotoxicity
Current Genomics p53 Activation by Blocking Snail : A Novel Pharmacological Strategy for Cancer
Current Pharmaceutical Design Therapeutic Targets for the Management of Peripheral Nerve Injury- Induced Neuropathic Pain
CNS & Neurological Disorders - Drug Targets Inflammation and Cancer: When NF-κB Amalgamates the Perilous Partnership
Current Cancer Drug Targets Drugs as Possible Triggers of Takotsubo Cardiomyopathy: A Comprehensive Literature Search - Update 2015
Current Clinical Pharmacology A Facile and Microwave-assisted Rapid Synthesis of 2-Arylamino-4-(3′-indolyl)- thiazoles as Apoptosis Inducing Cytotoxic Agents
Anti-Cancer Agents in Medicinal Chemistry A Potential Anticancer Agent 1,2-di(quinazolin-4-yl)diselane
Letters in Drug Design & Discovery Spirooxindoles as Potential Pharmacophores
Mini-Reviews in Medicinal Chemistry Role of ZEB Family Members in Proliferation, Metastasis, and Chemoresistance of Prostate Cancer Cells: Revealing Signaling Networks
Current Cancer Drug Targets Prospects for Plant-Derived Chemopreventive Agents Exhibiting Multiple Mechanisms of Action
Current Medicinal Chemistry - Anti-Cancer Agents